organophosphonates has been researched along with HTLV-I Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chizzolini, C; Landis, T; Perren, F; Pot, C; Ribi, C; Tiercy, JM; Vokatch, N | 1 |
| Ascolani, A; Balestrieri, E; Chiacchio, U; Macchi, B; Mastino, A; Matteucci, C; Piperno, A; Romeo, G; Romeo, R | 1 |
2 other study(ies) available for organophosphonates and HTLV-I Infections
| Article | Year |
|---|---|
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Female; HTLV-I Infections; Humans; Immunosuppressive Agents; Lamivudine; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Organophosphonates; Prednisone; Radiography; Sjogren's Syndrome; Tenofovir | 2006 |
Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.
Topics: Anti-Retroviral Agents; Aza Compounds; Cell Line; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukocytes, Mononuclear; Nucleosides; Organophosphonates; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2008 |